eyonis® LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction in operating loss in 2025 year‑over‑year, demonstrating strengthened cost discipline and operational efficiency iCRO order backlog reaches a new record at €79.8 million as of March 31, 2026 Cash and … [Read more…]
MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR—Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings … [Read more…]
Trial will evaluate visugromab’s potential to reverse cancer-associated weight loss and muscle wasting by targeting GDF-15 in patients with advanced solid tumors Fourth Phase 2b study of visugromab broadens CatalYm’s late-stage development program into severe cancer-associated condition impacting treatment outcomes MUNICH & SAN FRANCISCO–(BUSINESS WIRE)–CatalYm today announced that the first patient has been dosed in … [Read more…]
Samsung Bioepis recorded Q1’26 revenue of KRW 454.9 billion and operating profit of KRW 144.0 billion INCHEON, Korea–(BUSINESS WIRE)–#ADC–Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026. “Samsung Bioepis delivered solid growth this quarter driven by … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Advanced Sterilization Products (ASP), a global leader in infection prevention and low‑temperature sterilization, today announced a strategic partnership with ChemDAQ, a leading provider of hazardous gas detection and monitoring solutions. Together, ASP and ChemDAQ will support healthcare organizations by strengthening safety practices, reinforcing regulatory confidence, and advancing best‑in‑class sterile processing environments. As part … [Read more…]
Thursday, April 23, 10:00 AM EDT Miami, USA, via Zoom MIAMI–(BUSINESS WIRE)–#COVID–AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Will Equity Prevail? The PABS Annex Negotiations at Their Final Hour,” on Thursday, April 23, 2026 at 10:00 AM EDT, virtually via Zoom. Register here. … [Read more…]
In 2025, the Foundation directed nearly $6.4 million in philanthropic investments through grants, employee giving and matching contributions. PORTLAND, Ore.–(BUSINESS WIRE)–Cambia Health Foundation released its 2025 Community Impact Report, highlighting purposeful philanthropic funding to advance whole-person health and the dedication Cambia employees demonstrated through volunteerism and monetary giving. The Foundation’s strategic investments aim to expand … [Read more…]
RMA Basking Ridge (#8 Overall, #1 in NJ), Boston IVF Waltham (#11 Overall, #2 in MA), Conceptions RMA Colorado (#2 in CO), Ohio Reproductive Medicine (#2 in OH), UNC Fertility (#2 in NC) and others included on list of top 140 U.S. clinics BASKING RIDGE, N.J.–(BUSINESS WIRE)–IVI RMA North America, a leader in fertility care … [Read more…]
DMX-1001 (oral noribogaine) is a novel neuroplastogen therapeutic that combines neuroplasticity and polypharmacology for the treatment of AUD AUD affects more than 29 million Americans and is a leading cause of preventable death; about 60 percent of patients treated for AUD relapse to hazardous drinking within six months Successful completion of the planned alcohol interaction … [Read more…]
The proposed combination will create a differentiated global biosimilars platform that leverages Kashiv BioSciences’ development and manufacturing capabilities with Amneal Pharmaceuticals’ commercial strengths Complementary acquisition will accelerate biosimilar pipeline and strengthen U.S. commercial position for affordable medicines PISCATAWAY, N.J.–(BUSINESS WIRE)–Kashiv BioSciences, LLC (“Kashiv”), today announced that it has entered into a definitive agreement to be … [Read more…]
